Atlas Trials

A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD

Clinical trial NCT05822908 · RECRUITING

Trial details

NCT number
NCT05822908
Sponsor
Vico Therapeutics B. V.
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Spinocerebellar Ataxia Type 1Spinocerebellar Ataxia Type 3Huntington Disease
Start date
2023-02-14
Primary completion
2028-04-01
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.